Skip to Content

Tag: Hammaad Adam

MIT and Mass General Hospital researchers find disparities in organ acceptance

Most computational research in organ allocation is focused on the initial stages, when waitlisted patients are being prioritized for organ transplants. In a new paper presented at ACM Conference on Fairness, Accountability, and Transparency (FAccT) in Athens, Greece, researchers from MIT and Massachusetts General Hospital focused on the final, less-studied stage: organ offer acceptance, when an offer is made and the physician at the transplant center decides on behalf of the patient whether to accept or reject the offered organ. Learn more
Portrait of Hammaad Adam

Growing our donated organ supply

For those in need of one, an organ transplant is a matter of life and death.

Every year, the medical procedure gives thousands of people with advanced or end-stage diseases extended life. This “second chance” is heavily dependent on the availability, compatibility, and proximity of a precious resource that can’t be simply bought, grown, or manufactured — at least not yet.

Instead, organs must be given — cut from one body and implanted into another. And because living organ donation is only viable in certain cases, many organs are only available for donation after the donor’s death.

Unsurprisingly, the logistical and ethical complexity of distributing a limited number of transplant organs to a growing wait list of patients has received much attention. There’s an important part of the process that has received less focus, however, and which may hold significant untapped potential: organ procurement itself. Learn more
image description